trending Market Intelligence /marketintelligence/en/news-insights/trending/ZHOOwGydHEoTj9pLAPM4vA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Conformis signs stock purchase deal with Lincoln Park Capital Fund

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Conformis signs stock purchase deal with Lincoln Park Capital Fund

Conformis Inc. signed a common stock purchase agreement and registration rights agreement with asset manager Lincoln Park Capital Fund LLC.

Upon entering the deals, the Chicago-based fund acquired $1 million of Conformis stock at 52 cents per share.

The agreements give Conformis the right to sell Lincoln Park Capital up to $20.0 million of its shares within three years. Purchase price per share will be based on prevailing market prices.

Additionally, Conformis said it issued 354,430 shares as consideration for Lincoln Park Capital's commitment to purchase its common shares.

Conformis may terminate the agreements at any time without any cost or penalty.

Billerica, Mass.-based Conformis, which develops and sells joint replacement implant devices, will use proceeds for general corporate purposes.